Search - tctmd.com

Displaying 641 - 660 of 1333

Sort: Relevancy | Date

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

News Industry News

Medeon Biodesign Announces Successful First-in-man Studies for Large Bore Vascular Closure Device

November 02, 2015

News Opinion Fellow Talk

A Fellow’s Take on Technology: Looking Closer at the CardioMems and CardioHelp Devices

Sarah Elsayed, MD

October 28, 2015

News Industry News

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

October 27, 2015

News Daily News

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Todd Neale

October 26, 2015

News Daily News

Aprobado el Idarucizumab, Primer Antídoto de NOAC; El Deseo es no Demorar las Intervenciones

Todd Neale

October 26, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

Presentation TCT 2015

Can We Reduce Femoral Bailout Rates? Role of Ulnar Artery Access

Presenter: Olivier F. Bertrand, Sasko Kedev

October 15, 2015

Presentation TCT 2015

Does Radial Proficiency Affect Femoral Expertise?

Presenter: Sanjit S. Jolly, Sunil V. Rao, James Nolan

October 15, 2015

Presentation TCT 2015

Access Site and Radiation Exposure: Radial vs Femoral

Presenter: Sanjit S. Jolly, Sunil V. Rao

October 15, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

Presentation TCT 2015

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Michael J. Reardon

October 12, 2015

Presentation TCT 2015

Poor Femoral Access and TAVR (Alternative Access): Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Richard Smalling

October 12, 2015

News Conference News TCT 2015

DRAGON: Transradial as Effective as Transfemoral in Ad Hoc PCI, With Less Risk of Bleeding

October 12, 2015

News Industry News

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

October 12, 2015

Presentation TCT 2015

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Femoral Access and Related Complications

Presenter: Jose M. Wiley, Arnold Seto

October 11, 2015

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Conference News TCT 2015

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Nicole Lou

October 11, 2015

Advertisement

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

Medeon Biodesign Announces Successful First-in-man Studies for Large Bore Vascular Closure Device

A Fellow’s Take on Technology: Looking Closer at the CardioMems and CardioHelp Devices

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Aprobado el Idarucizumab, Primer Antídoto de NOAC; El Deseo es no Demorar las Intervenciones

My Takeaways From TCT 2015

Can We Reduce Femoral Bailout Rates? Role of Ulnar Artery Access

Does Radial Proficiency Affect Femoral Expertise?

Access Site and Radiation Exposure: Radial vs Femoral

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

Poor Femoral Access and TAVR (Alternative Access): Case Presentation

DRAGON: Transradial as Effective as Transfemoral in Ad Hoc PCI, With Less Risk of Bleeding

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Femoral Access and Related Complications

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content